Neuroscience Products CATALOG CATALOG NUMBER U.S. $ NUMBER U.S. $ -A- 3-(N-ACETYLAMINO)-5-(N-DECYL-N- 1 mg 27.50 159549 METHYLAMINO)BENZYL ALCOHOL 5 mg 89.40 o A23187 0-5 C [103955-90-4] (ADMB) See: Antibiotic A23187 A Protein Kinase C activator. Ref.: Proc. Nat. Acad. Sci. USA, 83, 4214 AA-861 20 mg 72.70 (1986). 159061 Purity: 95% 100 mg 326.40 C20H34N2O2 MW 334.5 0oC Orally active, specific and potent inhibitor of 5-lipoxygenase. N-ACETYL-ASP-GLU 25 mg 45.00 153036 [3106-85-2] 100 mg 156.00 Ref.: 1. Yoshimoto, T., et.al., Biochim. o Biophys. Acta, 713, 470 (1982). 2. Ashida, -20-0 C An endogenous neuropeptide with high 250 mg 303.65 Y., et.al., Prostaglandins, 26, 955 (1983). 3. affinity for a brain "Glutamate" receptor. Ancill, R.J., et.al., J. Int. Med. Res., 18, 75 Ref: Zaczek, R., et al., Proc. Natl. Acad. (1990). Sci. (USA), 80, 1116 (1983). C21H26O3 MW 326.4 C11H16N2O8 MW 304.3 ABL PROTEIN TYROSINE KINASE 250 U 47.25 N-ACETYL-2-BENZYLTRYPTAMINE 195876 (v-abl) 1 KU 162.75 See: Luzindole -70oC Recombinant Expressed in E. coli ACETYL-DL-CARNITINE 250 mg 60.00 A truncated form of the v-abl protein 154690 [2504-11-2] 1 g 214.00 tyrosine kinase which contains the 0oC Hydrochloride minimum region needed for kinase activity Crystalline and fibroblast transformation. Suppresses C9H17NO4 • HCl MW 239.7 apoptosis and induces resistance to anti-cancer compounds. O-ACETYL-L-CARNITINE CHLORIDE 500 mg 11.45 Activity: 100 KU/ml 159062 [5080-50-2] 1 g 20.65 Unit Definition: one unit is the amount of 0-5oC (R-(-)-2-Acetyloxy-3-carboxy-N,N,N-trimethyl 5 g 97.45 enzyme which catalyzes the transfer of 1 -1-propanaminium chloride) pmol of phosphate to EAIYAAPFAKKK per Purity: >88% minute at 30°C, pH 7.5. A cholinergic agonist that stimulates Contains no detectable phosphatase and neuronal response to serotonin and protease and only trace amounts of RNase acetylcholine. and DNase. C9H18NO4Cl MW 239.7 MW 45 kDa ACETYLCHOLINE CHLORIDE, 50µCi 251.35 17032 14 250µCi 995.00 ACACETIN 10 mg 17.50 o [ACETYL-1- C] 193972 [480-44-4] 50 mg 85.00 0-5 C Sp. Act. 1-10 mCi/mmol 0-5oC (5,7-Dihydroxy-4′-methoxyflavone) 37-370 MBq/mmol Possesses antioxidant properties and an Ethanol inhibitor of rat liver glutathione Ref.: Nicholas, C., et al., J. Neurochem., S-transferase. 62, 1835-1839 (1994). Ref.: Zhang, K. and Das, N.P., Biochem. CH3CO2CH2CH2N(CH3)3Cl MW 181.6 Pharmacol., 47, 2063 (1994). ACETYL COENZYME A 1 mg 11.25 C16H12O5 MW 284.3 100490 [72-89-9] 5 mg 27.85 o ACETATE KINASE 250 U 50.00 0 C Trilithium Salt 10 mg 50.50 154678 [9027-42-3] 1 KU 189.80 Trihydrate 25 mg 111.15 o Purity: 92-95% 100 mg 359.00 0-5 C (ATP: Acetate phosphotransferase) • EC 2.7.2.1 C23H35Li3N7O17P3S 3H2O MW 881.1 From Escherichia coli N-ACETYL-L-CYSTEINE 25 g 22.00 Activity: 150-300 units/mg protein (Biuret). 100098 [616-91-1] 50 g 36.75 Unit Definition: One unit will 0-5oC Crystalline 100 g 66.25 phosphorylate 1.0 µmole of acetate to Purity: >96% 500 g 223.30 acetylphosphate per min at pH 7.6 at 25°C. A mucolytic agent for isolation of 1 kg 365.20 Suspension in 3.2 M (NH4)2SO4 solution, mycobacteria from sputum. pH approx. 6.0. C5H9NO3S MW 163.2 Contains less than 0.01% glutamic-oxalacetic transaminase, lactic N-ACETYL-L-CYSTEINE 5 g 12.75 dehydrogenase, myokinase and NADH 194603 [616-91-1] 10 g 20.00 oxidase. 0-5oC Cell Culture Reagent 25 g 28.10 Crystalline 50 g 45.00 ACETOHEXAMIDE 1 g 22.05 Purity: >96% 100 g 84.25 193572 [968-81-0] 5 g 88.20 A mucolytic agent for isolation of 500 g 260.20 RT (4-Acetyl-N-[(cyclohexylamino)- mycobacteria from sputum. carbonyl]benzenesulfonamide) C5H9NO3S MW 163.2 Hypoglycemic agent 14 L µ 1332.80 C15H20N2O4S MW 324.4 N-ACETYL- -CYSTEINE, [1- C] 50 Ci 16010 Sp. Act. 25-50 mCi/mmol o ACETOPROMAZINE 1 g 10.30 0-5 C 0.925-1.85 GBq/mmol 154683 [61-00-7] Ethanol solution. RT (2-Acetyl-10-[3-dimethyl-aminopropyl]phenot HSCH2CH(NHCOCH3)COOH hiazine) MW 163.2 Maleate Salt • 4-ACETYL-1,1-DIMETHYL- 5 mg 59.65 C19H22N2OS C4H4O4 MW 442.5 159683 PIPERAZINIUM IODIDE 10 mg 108.95 N-[2-(ACETOXY)ETHYL]-3- 1 mg 19.00 RT A nicotinic acid agonist 25 mg 217.85 159681 PYRIDINECARBOXAMIDE 5 mg 75.00 C8H17N2OI MW 284.1 o 0-5 C (Nicorandil Analog; SG-209) 10 mg 121.00 N-ACETYLDOPAMINE 10 mg 16.80 An analog of nicorandil that acts as a 25 mg 253.00 150229 [2494-12-4] 25 mg 33.10 nitrate-free vasodilator through activation of 0oC Crystalline 100 mg 90.10 potassium channels. Metabolite of dopamine 500 mg 247.20 C10H12N2O3 MW 207.2 C10H13NO3 MW 195.2 To place an order: (800) 854-0530, fax (800) 334-6999 1146 www.icnbiomed.com Outside the U.S.: (714) 545-0100, fax (714) 557-4872 Email: [email protected] Neuroscience Products CATALOG CATALOG NUMBER U.S. $ NUMBER U.S. $ γ-ACETYLENIC GABA 1 mg 11.00 N-α-ACETYLGLYCYL-L-LYSINE 100 mg 8.80 193573 [57659-38-3] 5 mg 44.10 100182 METHYL ESTER 250 mg 17.80 RT (4-Amino-5-hexynoic acid) 25 mg 198.45 0oC [14752-92-2] 1 g 60.90 A GABA transaminase inhibitor. (AGLME) 5 g 280.55 Ref.: Schousboe, et al., Neurochem. Res., Acetate Salt 11, 1497 (1986). Crystalline C6H9NO2 MW 127.1 Substrate for measurement of urokinase activity. Ref.: Walton, P.L., Biochem. Biophys. Acta, N-ACETYL-S-FARNESYL-L-CYSTEINE 5 mg 71.35 132, 104 (1967). 159030 (AFC) 25 mg 306.00 C11H21N3O4 • C2H4O2 MW 319.4 o -20 C Purity: 98% 5 mg 59.65 Specific inhibitor of S-farnesyl- 1-ACETYL-4-METHYLPIPERAZINE cysteinemethyl transferase. Also prevents 159684 Hydrochloride 10 mg 108.95 carboxyl methylation of p21ras RT A nicotinic acid agonist 25 mg 217.85 platelet RAP C H N O • HCl MW 178.7 1 and the transduction γ subunit. 7 14 2 Ref.: 1. Volker, C., et.al., J. Biol. Chem., N-ACETYLNEURAMINIC ACID 10 mg 12.65 266, 21515 (1991). 2. Huzoor-Akabar, 194605 [131-48-6] 25 mg 25.35 et.al., ibid., 266, 4387 (1991). 3. 0-5oC (Sialic Acid; NANA; Type IV) 100 mg 66.15 Perez-Sala, D., et.al., Proc. Natl. Acad. Sci. Cell Culture Reagent 250 mg 145.55 USA, 88, 3043 (1991). From E. coli 500 mg 248.05 MW 367.5 White crystalline powder 1 g 439.90 Purity: ≥98% C11H19NO9 MW 309.3 N-ACETYL-S-FARNESYL-L- 50 µCi 605.15 3 5 mg 10.50 26020 CYSTEINE, [Cysteine-1- H] 250 µCi 1817.90 N-ACETYLNEURAMINIC ACID o 195854 [131-48-6] 25 mg 37.80 0-5 C Sp. Act. 10-20 Ci/mmol o 370-740 MBq/mmol 0-5 C (Sialic Acid; NANA) 100 mg 131.25 Ethanol From Bovine Milk Shipped in dry ice. C11H19NO9 MW 309.3 Please call for delivery information. N-ACETYLNEURAMINIC ACID 10 mg 12.60 MW 367.5 195855 [131-48-6] 50 mg 52.50 0-5oC (Sialic Acid; NANA) 250 mg 236.25 From Egg N-ACETYL-S-GERANYL-L-CYSTEINE 1 mg 20.20 Purity: ≥97% 195681 (AGC) 5 mg 92.40 C11H19NO9 MW 309.3 -20oC Purity: 98% A biologically inactive close structural N-ACETYL-PHE-NLE-ARG-PHE 0.5 mg 18.00 153039 1 mg 30.00 analog of AFC and AGGC. Used as a o AMIDE negative control. -20-0 C [83903-28-0] 5 mg 131.00 MW 299.4 A molluscan cardioexcitatory neuropeptide analog. C23H46N8O5 MW 622.8 N-ACETYL-S-GERANYLGERANYL-L- 5 mg 131.90 N-ACETYLPROCAINAMIDE 250 mg 11.95 159845 10 mg 229.30 193574 1 g 37.95 o CYSTEINE [34118-92-8] -20 C [139332-94-8] -20oC (4-(Acetylamino)-N-[2-(diethylamino)ethyl]ben (AGGC) zamide) Purity: 98% Hydrochloride Specifically inhibits methyl esterification of A metabolite of procainamide that blocks geranylgeranylated proteins. Also, it blocks potassium channels and exhibits some signal transduction in human neutrophils antiarrhythmic activity. that are receptor mediated. C15H23N3O2 • HCl MW 313.8 Ref.: 1. Phillips, M.R., et al., Science, 259, 977 (1993). N-ACETYL-D-SPHINGOSINE 1 mg 12.10 158923 [3102-57-6] 5 mg 40.20 2. Volker, C., et al., FEBS Lett., 295, 189 o (1991). -20 C (C2 Ceramide; N-Ethanoyl-D-sphingosine; MW 435.7 Acetyl ceramide) Purity: 98% Inhibitor of cell proliferation and inducer of β 1 mg 28.00 monocytic differentiation of HL-60 cells. N-ACETYL-D-GLUCOSAMINYL- - Stimulates cytosolic serine/threonine 158221 → 5 mg 125.95 o (1 4)-N-ACETYLMURAMYL-L- protein phosphatase in T9 cells at low -20 C ALANYL-D-ISOGLUTAMINE concentrations. (GMDP) Ref.: 1. Kim, M.-Y., et.al., J. Biol. Chem., Purity: 98% 266, 484 (1991). 2. Okazaki, T., et.al., ibid., Lyophilized 265, 15823 (1990). 3. Dobrowsky, R.T. and A novel synthetic analog of bacterial cell Hannun, Y.A., et.al., J. Biol. Chem., 267, wall glycopeptide which acts as a 5048 (1992).